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Abstract We introduce a simple micro-fluidic device
containing an actuated flexible membrane, which allows
the viscoelastic characterization of cells in small volumes of
suspension by loading them in compression and observing
the cell deformation in time. From this experiment, we can
determine the characteristic time constant of recovery of the
cell. To validate the device, two cell types known to have
different cytoskeletal structures, 3T3 fibroblasts and HL60
cells, are tested. They show a substantially different
response in the device and can be clearly distinguished on
the basis of the measured characteristic recovery time
constant. Also, the effect of breaking down the actin
network, a main mechanical component of the cytoskele-
ton, by a treatment with Cytochalasin D, results in a
substantial increase of the measured characteristic recovery
time constant. Experimental variations in loading force,
loading time, and surface treatment of the device also
influence the measured characteristic recovery time con-
stant significantly. The device can therefore be used to
distinguish between cells with different mechanical struc-
ture in a quantitative way, and makes it possible to study
changes in the mechanical response due to cell treatments,
changes in the cell’s micro-environment, and mechanical
loading conditions.
Keywords Cell characteristic recovery time constant.
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1 Introduction
The internal structure of most biological cells is governed
by the cytoskeleton. This network of protein filaments
provides a continuous, dynamic connection between nearly
all intracellular structures. The cytoskeleton is involved in
regulating cell shape and resistance to deformation. It also
plays a role in active processes such as cell division,
locomotion and the transport of intracellular particles
(Alberts et al. 2008). The cytoskeletal structure determines
the mechanical properties of a cell, such as its stiffness and
its time-dependent response to mechanical stimuli.
As a consequence, different types of cells having a
different cytoskeleton, will have different mechanical
properties. Depending on its stage of development a
specific type of cell may show a development in stiffness
due to the corresponding change in cytoskeleton. Also,
many diseases significantly change the stiffness of cells by
a rearrangement of the cytoskeletal structure. Known
examples are cancer (Lekka et al. 1999; Suresh et al.
2005; Suresh 2007), malaria (Glenister et al. 2002; Suresh
et al. 2005), atherosclerosis (Wautier et al. 1999), and
cardiac myopathies (Bornemann and Goebel 2001). On the
basis of a reliable measurement of mechanical properties of
cells, in particular cell stiffness and time-dependent
responses, it should therefore be possible to distinguish
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isolate affected cells from healthy cells for a variety of
diseases.
Several techniques exist for the measurement of cellular
mechanical properties. The techniques can be roughly
divided into those methods that probe only part of the cell,
and those that deform cells globally. The first category
includes techniques such as atomic force microscopy
(AFM) (Rotsch and Radmacher 2000; Rosenbluth et al.
2006), magnetic twisting cytometry (Maksym et al. 2000;
Puig-de-Morales-Marinkovic et al. 2007), cytoindentation
(Suresh 2007), and micro-rheology measurements (Wirtz
2009). Although these approaches can provide a quantita-
tive mechanical analysis, a disadvantage is that the response
may depend significantly on the precise measurement
location, since only part of the cell is probed. As a result,
these techniques generally show a large cell-to-cell spread.
Techniques in which cells are deformed globally are laser/
optical cell stretching (Dao et al. 2003), microplate
stretching (Thoumine and Ott 1997), micropipette aspira-
tion (Evans and Yeung 1989; Hochmuth 2000) and cell
compression testing (Peeters et al. 2005).
Many of these techniques are performed on a per-cell
basis. Therefore, they require single-cell handling which
can make them very tedious and slow (several cells per
hour). Furthermore, in many methods it is difficult to
control the micro-environment around the cells to be tested,
which would be desirable for testing the effect of
environment on mechanical properties, or for creating
physiologically relevant conditions.
Recently, micro-fluidic approaches have been used to
characterize the mechanical properties of biological cells. A
micro-fluidic device contains sub-millimeter channels and
chambers, down to sizes of just a few micrometers, in
which liquids and (bio-)molecules can be manipulated. One
advantage of micro-fluidics is that it offers opportunities to
study mechanical properties of single, non-isolated cells in
a controlled micro-environment, such as a capillary-like
microenvironment under physiological conditions, for
example in fresh blood. An additional advantage of
micro-fluidic devices is that high-throughput testing of
cells is possible by a proper design of the micro-fluidic
channel structure, so that a statistical analysis can be done
while the testing time is limited.
Shelby et al. qualitatively monitored the deformability and
the shape recovery time of single uninfected and malaria
infected red blood cells by flushing through capillary-like
channels in such a micro-fluidic chip (Shelby et al. 2003).
Rosenbluth et al. developed a micro-fluidic device that
resembles the micro-capillary network in vivo, and charac-
terized the properties of leukemic cells (Rosenbluth et al.
2008). Guck et al. combined an optical stretcher and a
micro-fluidic channel to study the stiffness of normal and
cancerous fibroblasts and epithelial cells (Guck et al. 2005).
We have used another micro-fluidic device to character-
ize the time-dependent mechanical properties of cells. The
working principle of our device is sketched in Fig. 1.I t
consists of two flow reservoirs, separated by a flexible
elastomeric membrane. During experiments, the control
chamber is filled with water and the cell chamber contains a
cell suspension. The control chamber is pressurized, so that
the flexible membrane deflects into the cell chamber, touches
the cells,anddeforms them.Thisprocess isobservedusing an
optical microscope. After a sudden release of the pressure, the
membrane returns to its original position, and the cells
recover, in time, back to their undeformed state. From the
observation of this process over time, the global viscoelastic
timeconstantofthe cellscanbeestimated,whichisa measure
of their viscoelastic mechanical response.
As a proof-of-concept of this method, we have measured
the characteristic time constants of two cell types known to
have different cytoskeletal structures, namely white blood
cells from the HL60 neutrophilic cell line, and 3T3
fibroblast cells. Also, we have studied the effect of the
variation of several parameters such as surface treatment of
the device, disruption of the actin network of the cells using
Cytochalasin D, and other experimental parameters. The
deviceproposedbyKim etal. isanalogous toour device; they
used it to mechanically induce cellular damage in epithelial
cells, and for mechanical lysis of cells (Kim et al. 2007).
2 Materials and methods
2.1 The micro-fluidic device
Our micro-fluidic device consists of a polydimethylsiloxane
(PDMS) structure bonded to a glass substrate, as shown in
control chamber cell chamber
microscope (a) (b)
Fig. 1 The working principle of our device, illustrated by a cross-
sectional sketch (not drawn to scale). (a) The non-actuated state. (b)
The control chamber is pressurized, and the deflecting membrane
deforms the cells present in the cell chamber; cell deformation is
monitored by a high-speed camera connected to the optical
microscope
30 Biomed Microdevices (2011) 13:29–40Fig. 2. The cell chamber is 100 μm in height and 15×5 mm
in the lateral directions, and the control chamber is also
100 μm high but has lateral dimensions 10×5 mm. To keep
the flexible membrane flat in the beginning of the
experiment, a relatively thick PDMS membrane is used, i.e.
about 500 μmt h i c k .
The microfluidic device was fabricated from PDMS
silicone elastomer using multilayer soft lithography as
illustrated in Fig. 3 (Unger 2000). A layer (5 mm thick)
was formed by pouring the PDMS prepolymer-crosslinker
mixture (Dow Corning Sylgard 184, 10:1 ratio of prepolymer
to crosslink agent) onto a mold that contained the (negative)
shape of the control chamber (step 1 in Fig. 3). The mold had
been fabricated using SU-8 processing on a glass substrate.
The PDMS was cured on a hotplate for 30 min at a
temperature of 80°C. To make the PDMS membrane, the
PDMS prepolymer-crosslinker mixture was poured on a
piece of glass (glass A in Fig. 3) and the glass was kept
standing at 85° with the horizontal for about 1 min allowing
the PDMS to flow, resulting in a 500 μm thick PDMS film
that was subsequently cured at 80°C. Both the layers peeled
from the mold and the film were treated by a handheld
corona treater (Electro-Technic Products, see Haubert et al.
2006) for 15 s to activate the surfaces before bonding the
two surfaces together. Then, the PDMS film plus top layer
was peeled off from the glass substrate (Step 2, Fig. 3). To
fabricate the bottom chamber, another PDMS film was made
using the process described earlier, and manually a square
area (15×5 mm) was cut out from the film and removed
from its glass substrate (glass B in Fig. 3). The remaining
PDMS was treated by the corona treater for 15 s to bond
with the PDMS layer made before (Step 3, Fig. 3). The
whole PDMS construction was then peeled off from glass B.
Finally, the complete PDMS part was treated by the corona
treater and bonded to a clean glass substrate (glass C in
Fig. 3), to finally form the bottom cell chamber (Step 4 in
Fig. 3).
To form the fluidic connections, the PDMS layers were
punched by 7 G flat needles (BD) and self-made tips were
inserted for connection with syringes.
2.2 Cell culture and treatments
We used two types of cell for the experiments reported
here, namely HL60 cells and 3T3 fibroblast cells. HL60
cells are human promyelocytic leukemia cells. They are
predominantly a neutrophilic promyelocyte (precursor).
3T3 cells are from a standard fibroblast cell line. It is
known that these cells have different mechanical proper-
ties due to a difference in cytoskeletal structure: for
adherent 3T3 cells, an elastic modulus of 3–12 kPa was
measured with AFM (Rotsch et al. 1999); for HL60, a
value of 0.2–1.4 kPa was found using AFM (Rosenbluth
et al. 2006).
The HL60 cells were grown in RPMI 1640 medium
(32404-014, Invitrogen Ltd, United Kindom) supplemented
with 10% fetal bovine serum (FBS) and 1% L-glutamine.
The 3T3 cells were cultured in DMEM (BE12-707F, Lonza,
Switzerland) supplemented with 10% FBS, 5% Penicillin/
Streptomycin (Lonza, Switzerland) and 1% L-glutamine.
The 3T3 cells were detached from the culture flasks by
trypsin. After centrifugation at 1,000 rpm for 5 min (for
both cell types), the old medium was carefully removed and
the remaining cell suspension was resuspended with 10 mL
of its own fresh medium.
In some of the experiments, the cells were pre-treated by
Cytochalasin D (CytoD). This is known to disrupt actin,
which forms one of the components of the cytoskeleton of
cells (Goddettes and Frieden 1986). Hence, this intentional
disruption of the cell structure enables to study its influence
on the mechanical properties, in particular recovery time, in
our measurements. Both the HL60 and the 3T3 cells were
exposed to 4 μM CytoD (Sigma) for 1 h. After that, the
cells were removed from the flask and centrifuged at
1,000 rpm for 5 min. The medium was carefully removed
and the cells were resuspended in 10 mL of their own fresh
medium.
The change in cytoskeletal structure by the CytoD
treatment was assessed by staining actin filaments with
phalloidin and subsequent imaging with fluorescent
microscopy. Briefly, 3T3 cells were seeded and grown
Fig. 2 Our PDMS-based device
consists of two micro-fluidic
chambers separated by a flexible
PDMS membrane
Biomed Microdevices (2011) 13:29–40 31for 2 days on coverslips coated with 0.1% gelatin. HL60
suspensions (around 2×10
4 cells) were spun down on
slides in a cytocentrifuge for 10 min at 500 rpm (Rotofix
32 A, Hettich, Tuttlingen, Germany). After fixation in
f o r m a l i n ,b o t h3 T 3a n dH L 6 0c e l l sw e r ei n c u b a t e df o r
10 min in 0.5% Triton-X-100 to improve antibody
penetration. Non-specific binding was avoided by incuba-
tion in 1% horse serum (HS) for 20 min. Then, samples
were stained in dark for 1 h with phalloidin fluorescein
isothiocyanate (1:200, Sigma, Netherlands) in order to
visualize filamentous actin and were counterstained with
DAPI (Sigma, Netherlands) in order to visualize nuclei. It
should be noted that, contrary to the experimental
condition in the micro-fluidic device, the 3T3 cells were
a l l o w e dt oa t t a c hb e f o r es t a i n ing. The cytoskeletal struc-
ture in the staining experiment might then not be fully
representative of the experimental situation, however it
does show the effect of CytoD on the actin filaments.
Figure 4 shows the fluorescent images obtained for both
cells, with and without treatment by CytoD. It is clear that
after CytoD treatment, in 3T3 cells the long actin filament
bundles have been disrupted and short, not-cross-linked
aggregates of F-actin are present. For HL60 cells, the effect
is less evident but still a strong disintegration of actin
cytoskeletal structure can be observed.
The figure also shows, by comparison of (c) and (i), that
the two cell types have a different cytoskeletal structure.
Stationary tightly adherent cells, such as 3T3 fibroblast, are
characterized by thick and well structured stress-fiber
bundles across the cell (Mitchison and Cramer 1996),
whereas such structures cannot be found in more motile
cells, such as HL60, where actin fibers are primarily
concentrated on the cortical shell area (Jeon 2002). This
difference can be seen in Fig. 4.
2.3 Measurement procedure
The cell chamber was treated by Pluronic F127 (Sigma
Aldrich Pluronic
® F-127, Zwijndrecht, Netherlands) which
acts to prevent cell adhesion to the PDMS (Wang et al.
2005); a 1.0% (w/w) F127 solution in water was left in the
device for 3 days. Prior to the experiment, the chamber was
flushed with phosphate buffered saline (PBS). The cells
were kept at 37°C in an incubator before use. At the start of
the experiment, the control chamber was filled with water
and connected to a syringe pump. In the cell chamber, that
was kept open to atmospheric pressure during the experi-
ments, a cell solution (around 6×10
6 cells/mL) was entered.
To start the membrane deflection, the syringe pump was
switched on at 4 μL/min, injecting water into to the control
chamber, and the PDMS membrane was deformed slowly
by the resulting pressure increase in the control camber. At
sufficient membrane deflection, the cells present in the cell
chamber were touched by the membrane and subsequently
deformed between the bottom wall and the membrane. The
deformation of the cells, which was visible as a change in
the observed projected surface area, was observed by a
microscope equipped with a camera. The pump was
stopped when a particular cell compression ratio was
reached, typically after 1 min. After a specific holding time
during which the cell deformation was kept constant, the
pressure was suddenly removed from the system and the
PDMS membrane unloaded in less than a second. The cell
started to recover back to its original shape and this process
was recorded.
All the cell recovery movies were recorded using an
optical microscope (Leica) and a CCD camera. The movies
were captured at 200× magnification at a frame rate of 15 Hz
andsplitbyMATLABtoone frame persecond.Theprojected
Fig. 3 Schematic of the fabri-
cation procedure of the device
32 Biomed Microdevices (2011) 13:29–40surface area of the cell was analyzed by Cellprofiler (http://
www.cellprofiler.org). All results discussed in the next
section are based on 5 or 6 individual measurements on
different cells.
A range of experiments was conducted, including the
following variations:
& Cell type: HL60; 3T3
& Cell treatment: no particular treatment; treatment
with Cytochalasin-D (see above)
& Surface treatment device: no treatment; three days
treatment with Pluronic F127
& Cell compression ratio at maximum load, defined as the
projected undeformed cell area divided by the area at
maximum compression: 0.3; 0.5; 0.7
& Holding time at maximum compression: 5 min, 30 min
The conditions in bold are the reference conditions.
2.4 Data analysis
Several mechanical models, with varying level of complex-
ity, have been used to describe the mechanical properties of
cells, see Lim et al. 2006 for an overview. The cell
Fig. 4 Fluorescence images of 3T3 (a–c), CytoD treated 3T3 (d–f),
HL60 (g–i), CytoD treated HL60 (j–l) stained with phalloidin (green,
showing actin) and DAPI (blue, showing nuclei). The first column
visualizes both the actin (green) and the nuclei (blue), whereas the
second and third columns show respectively the nuclei and the actin
only
Biomed Microdevices (2011) 13:29–40 33deformation images we obtain are analyzed by assuming
that the mechanical properties of the cells can be described
as a homogeneous linear viscoelastic solid model (LVS).
This was proposed by Schmid-Schonbein et al. 1981 to
study the deformation of human leukocytes undergoing
micropipette aspiration, and later applied by others to other
cell types, see e.g. Lim et al. 2006. The model includes an
elastic element (modulus G2) parallel to a Maxwell element,
in which another elastic element (modulus G1) and a
viscous element (viscosity η1) are combined. Mathemati-
cally, the model is represented by the equation:
s þ
h1
G1
 
ds
dt
¼ G2 g þ h1
G1 þ G2
G1G2

dg
dt

ð1Þ
In a recovery experiment, in which a stress is applied
and suddenly removed, just as in our device, this model
shows a recovery to the original strain according to the
following expression:
gðtÞ¼
G1
G1 þ G2
gmaxe
 G1G2t
G1þG2 ðÞ h1 ð2aÞ
in which γmax is the maximum strain just before starting the
recovery at t=0. The characteristic time constant of
recovery can thus be expressed by:
t ¼
G1 þ G2 ðÞ h1
G1G2
ð2bÞ
To apply Eqs. 2a and 2b we assume that the cell is
spherical with radius R0 in the undeformed state, and will
take an ellipsoidal shape during recovery, as sketched in
Fig. 5. Also, we assume that the cell volume remains
constant during the recovery process. The z-direction is
perpendicular to the deflecting membrane, i.e. the direc-
tion in which the cell is loaded. During recovery, the
length Rz lengthens, while Rx and Ry shorten equally, all
approaching the value R0 in the end. The quantity we
observe during the experiment is the projected cell area
given by:
AðtÞ¼pRxðtÞRyðtÞ¼pR2
xðtÞ¼p
R3
0
RzðtÞ
ð3Þ
T h ea r e as t r a i ni sd e f i n e db y :
"ðtÞ¼
AðtÞ
Amax
ð4Þ
in which Amax is the maximum projected area at maximum
deformation, just before unloading. The linear strain γ is
defined as:
gðtÞ¼
RzðtÞ R0
R0
¼
A0
AðtÞ
  1 ð5Þ
Fig. 5 The cell deformation process showing only the upper half of
the cell. (a) Before deformation; (b) during deformation. The z-axis is
oriented perpendicularly to the moving membrane
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Fig. 6 Left, images of the recovery of the cells at various points in
time, after sudden release of the pressure at t=0. (a) 3T3; (b) HL60.
Right, the recovery curves of 3T3 (solid blue), and HL60 (dashed
red), showing the change in time of the area ratio defined in Eq. 4.I n
these measurements, the reference measurement conditions were used.
Each marker represents one data point; the data points of multiple
cells are shown. The lines represent fits according to Eq. 7
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2.N o t et h a tγ is
negative in our experiments, since the cell is compressed.
The combination of Eqs. 4 and 5 yields:
gðtÞ¼
A0
Amax"ðtÞ
  1 ð6Þ
We assume now that Eqs. 2a and 2b applies to the linear
strain of Eq. 6. Effectively, we thereby assume that the
deformation process is uniaxial, which is only approxi-
mately true. Substitution of Eq. 6 into Eqs. 2a and 2b
results in:
"ðtÞ¼
1
Amax
A0   K Amax
A0   1

e t
t
ð7Þ
in which
K ¼
G1
G1 þ G2
andt ¼
G1 þ G2 ðÞ h1
G1G2
ð8Þ
where τ is now called the characteristic recovery time
constant of the cell.
Equation 7 was fitted to the measured recovery curves
using MATLAB to obtain K and the characteristic recovery
time constant τ. The fit was done for each individual cell
recovery curve separately, and subsequently the fit results
were averaged for all cells (typically 5 or 6 different cells)
for each condition or population. To assess the goodness of
fit, the percent relative standard deviation (%RSD) was
computed. To assess the significance of the differences in
fit parameters found, Student’s t-test were carried out and
p-values were calculated. Forp-values smaller than 0.01, the
differences were considered to be statistically significant.
3 Results and discussion
Figure 6 shows snapshots from a movie of the recovery
process of both an HL60 and a 3T3 cell. Also, the
corresponding recovery curves and the fitted function
according to Eq. 7 are depicted. In these experiments, the
reference experimental conditions were used, i.e. the cell
compression ratio at maximum load was 0.5, the holding time
at maximum compression was 5 min, the cells were not
treated with CytoD, and the device was treated with F127.
Both cell types gradually recover to their undeformed cell
compression ratio value of 0.5, and both cells seem to
undergo a slight instantaneous elastic response at t=0. These
Fig. 7 Average characteristic recovery time constants for the HL60
and the 3T3 cells under reference conditions
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Fig. 8 Cell recovery curves measured for different maximum cell
compression ratios. (a) 3T3 cells, for A0/Amax=0.6 (blue, N=6,%
RSD=4.8), 0.5 (black, N=6,%RSD=5.8) and 0.3 (red, N=6,%RSD=
4.7). (b) HL60 cells for A0/Amax=0.5 (black, N=6,%RSD=5.3), 0.4
(green, N=7,%RSD=5.2) and 0.3 (red, N=6,%RSD=5.4). N is the
number of cells tested for each condition. Each marker represents one
data point; the data points of multiple cells are shown. The lines
represent fits according to Eq. 7
Biomed Microdevices (2011) 13:29–40 35characteristics are consistent with the linear viscoelastic solid
model described in the previous section. It takes typically
100 s or more for the cells to recover completely. Clearly, the
3T3 fibroblast has a longer recovery time than the HL60 cells.
Fitting Eq. 7 to the measurement data enables us to
quantify the characteristic recovery time constants of the
cells, given by Eq. 8. The average over 6 measurements
(per cell type) is depicted in Fig. 7. The error bars represent
the standard deviation on the basis of these 6 measure-
ments. There is a significant difference between the
characteristic recovery time constant of HL60 (26 s) and
that of 3T3 (55 s). Hence, we can distinguish one type of
cell from the other by measuring its characteristic recovery
time constant. The measured values for K are 0.96±0.03
and 0.95±0.03 for HL60 and 3T3, respectively. This
difference is not statistically significant.
The difference in recovery response times correlates with
the entirely different cytoskeletal structure of the two cell
types. This difference in cell structure could be seen in
Fig. 4. Here, we should note that the 3T3 cells were
adherent to the substrate in the staining experiments of
Fig. 4, whereas they are in suspension in the recovery
experiments. In the suspended condition, a less organized
structure may be present due to the lack of tension forces at
the focal adhesion points; nevertheless, we expect the actin
structure still to be different in 3T3 compared to HL60 cells
in the experiments.
The effect of the maximum cell compression ratio A0/
Amax maintained during the holding period is shown in
Fig. 8; all other measurement conditions were equal to the
reference situation in these experiments. The corresponding
characteristic recovery time constants are summarized in
Fig. 9. The characteristic recovery time constant depends
on the maximum cell compression ratio. This proves that,
under these measurement conditions, the linear viscoelastic
model does not hold strictly, since for this model the
characteristic recovery time constant is a constitutive
parameter that should be independent of the deformation
or loading conditions. The reason is that the deformation
itself causes changes in the cells’ cytoskeletal structure such
that the effective cell properties change. Larger deforma-
tions (i.e. smaller cell compression ratios) result in longer
recovery times. For the 3T3 cells recovery times are longer
than for the HL60 cells over the entire range of cell
compression ratios tested. The fitted values of K for 3T3 are
Fig. 9 The characteristic recovery time constant of the HL60 and 3T3
cells compared, as a function of the maximum cell compression ratio
A0/Amax. The p-values indicate that the differences are statistically
significant
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Fig. 10 Recovery curves measured for cells untreated or treated
with cytochalasin D. (a) 3T3 cells: untreated, reference conditions
(black), treated with CytoD, A0/Amax=0.5 (green, N=6,%RSD=
4.8), treated with CytoD, A0/Amax=0.7 (blue, N=5,%RSD=3.0).
(b) HL60 cells: untreated, reference conditions (black), treated with
CytoD, A0/Amax=0.5 (green, N=6,%RSD=4.8), treated with
CytoD, A0/Amax=0.6 (blue, N=6,%RSD=3.9). N is the number
of cells tested for each condition. Each marker represents one data
point; the data points of multiple cells are shown. The lines represent
fits according to Eq. 7
36 Biomed Microdevices (2011) 13:29–400.97±0.02, 0.95±0.03, and 0.91±0.04 respectively for the
maximum cell compression ratios of 0.6, 0.5 and 0.3,
respectively. For HL60, these values are 0.98±0.02, 0.99±
0.02, and 0.96±0.03 for the cell compression ratios of 0.5,
0.4 and 0.3
The treatment with CytoD has a dramatic effect on the
cell properties, as is evidenced by Figs. 10 and 11. The
characteristic recovery time constant is greatly increased,
especially for the HL60 cells. As we have seen in Fig. 4,
the CytoD treatment disrupts the actin network in the cells,
and therefore it can be expected that the structural
coherence of the cell is at least partly lost. The elastic
component in response to deformation becomes therefore
more insignificant due to the treatment, which will result in
longer characteristic recovery time constants (see also Eq. 8
that shows that smaller elastic moduli in the LVS model
result in a larger characteristic recovery time constant τ),
which is what we observe. For the reference loading
conditions, τ increases from 55 s to 110 s for 3T3 cells
(i.e. a 100% increase), and from 26 s to 150 s for the HL60
cells (i.e. a 470% increase), see Fig. 11 compared with
Fig. 9. Particularly the latter change is substantial. The
values for K for the cytoD treated 3T3 cells are 0.95±0.02
and 0.93±0.034 respectively for the area ratios 0.7 and 0.5.
For the cytoD treated HL60 cells the fitted K is 0.99±0.03
and 0.98±0.04 for the area ratios 0.6 and 0.5.
Cellular shape, elasticity and contraction are to a large
extent determined by the actin structure of the cytoskeleton.
Therefore, the structural organization of actin fibers
determines the mechanical properties of the cell. For this
reason, disruption of actin by the CytoD treatment results in
a change of cytoskeletal organization and thus a change in
the mechanical response (Charras and Horton 2002; Olins
et al. 2000; Rotsch and Radmacher 2000; Wakatsuki et al.
2000). In previous studies, it has been shown that actin
microfilament disrupting drugs such as CytoD or latruncu-
lin B, diminished cell elasticity (Lekka et al. 1999) and
caused a dramatic reduction of cell stiffness (Glenister et al.
2002). Rosenbluth et al. found that the transit time of HL60
cells flowing through narrow micro-channels was decreased
substantially by a CytoD treatment (Rosenbluth et al.
2008). The characteristic recovery time constant increase
we observe is in line with this. This is due to the fact that
actin filaments provide and support contractile stresses
generated within the cell. It has been postulated that actin
filaments are anchored to the plasma membranes by barbed
end capping proteins and for this reason they provide
tensile forces in the cell (Wautier et al. 1999). CytoD
Fig. 11 The characteristic recovery time constant of both cell types
after treatment with Cytochalasin D, as a function of the maximum
cell compression ratio. A comparison with Fig. 9 shows that the
treatment results in a large increase of characteristic recovery time
constant
Fig. 12 The influence of the holding time on the characteristic
recovery time constant. (a) The characteristic recovery time constant
of 3T3 cells with a maximum compression ratio around 0.5 for a
holding time of 30 min (grey, N=4) and 5 min (white, N=6). (b) The
characteristic recovery time constant of HL60 cells with a maximum
compression ratio around 0.35 when with a holding time of 30 min
(grey, N=4) and 5 min (white, N=6). N is the number of cells tested
for each condition. The difference is not statistically significant for the
HL60 cells
Biomed Microdevices (2011) 13:29–40 37destabilizes these site of anchorage, disrupts the fibers and
consequently reduces the elasticity of the cell and the
ability to maintain cell shape. It might be postulated that
other cytoskeletal structures, such as microtubules and the
cell membrane, then take substantial part in the cell
recovery.
Figure 12 shows the effect of an increase of the holding
time at which the maximum load is maintained from 5 min
to 30 min. The change is dramatic: for the 3T3 cells the
characteristic recovery time constant increases to 340 s, i.e.
a 7-fold increase. The characteristic recovery time constant
increase for the HL60 cells is less, but seems still
substantial however the large p-value (p>0,01) indicates
that the change is not statistically significant. The most
probable explanation for the influence of the holding time is
that the cell structure is rearranged during the holding
period. The compression load acting on the cell influences
the continuous polymerization and depolymerization pro-
cesses that happen in the cytoskeleton, thereby substantially
changing the cell’s mechanical structure and properties, i.e.
biological remodeling takes place.
To illustrate the influence of the interaction of the cells
with the surface, Fig. 13 shows the effect of the Pluronic
F127 treatment of the device on the characteristic recovery
time constant. Both 3T3 and HL60 cells have a larger
characteristic recovery time constant for the untreated
surfaces, although the change is not statistically significant
for the HL60 cells. It is known that the Pluronic treatment
reduces the cell-surface adhesion (Wang et al. 2005).
Hence, the interaction between the cells and the surface,
in particular adhesion, is larger for the untreated than for the
treated surfaces. It is clear from Fig. 13 that the additional
interaction can slow down the cell recovery quite substan-
tially, in particular for the 3T3 cells.
Finally, Table 1 compares our values of the parameters K
and τ, with those derived from the LVS parameters G2 G1
and η1 published by other authors for various cell types and
using different methods. The value of K does not vary
much (between 0.35 and 0.96), at least compared to the
value of the characteristic recovery time constant that
ranges over orders of magnitude (from 0.3 to 116) for the
various cells and methods. Our value for the 3T3 fibroblast
is comparable to that measured with microplate stretching
by Thoumine and Ott for fibroblasts.
However, one should be very careful in directly
comparing these numbers. To a large extent, the variation
in τ-values is due to the differences in the structure of the
different cell types, but it is also due to differences in
Fig. 13 The effect of device surface treatment on the characteristic
recovery time constant. (a) The characteristic recovery time constant
of 3T3 for an untreated surface (grey, N=4) and of the F127 treated
surface (white, N=6), both for a maximum compression ratio of 0.3.
(b) The characteristic recovery time constant of HL60 when for an
untreated surface (grey, N=5) and in the F127 treated device (white,
N=6), both for a maximum compression ratio of 0.35. N is the
number of cells tested for each condition. Only for the 3T3 cells, the
difference is statistically significant
Table 1 Reported parameters for the homogeneous linear viscoelastic solid, compared to our results under reference conditions
Cell type K [-] τ [s] Method Reference
Myoblasts 0.48 0.3 Cell compression Peeters et al. 2005
Fibroblasts 0.35 39 Microplate stretching Thoumine and Ott 1997
Human leukocytes 0.73 0.65 Micropipette aspiration Schmid-Schönbein et al. 1981
Endothelial cells 0.67 116 Micropipette aspiration Sato et al. 1990
3T3 fibroblasts 0.95 55 Microfluidic membrane device The present work
HL60 neutrophilic promyelocytes 0.96 26 Microfluidic membrane device The present work
38 Biomed Microdevices (2011) 13:29–40loading devices, loading protocols, operating conditions,
and degree of cellular attachment. For example, the experi-
ments by Thoumine and Ott and by Sato et al. were done
by applying large strains during long timescales, whereas
the measurements by Peeters et al. and Schmid-Schönbein
et al. were performed at smaller strains and short time-
scales. Indeed, our own results show that experimental
conditions such as loading time and surface conditions can
have a large effect on the measured parameters. Strictly, the
wide variation of τ implies that the LVS model is not a
suitable quantitative constitutive model for this wide range
of conditions, although it can still be used to describe our
experiments qualitatively.
4 Conclusion
Our micro-fluidic device, based on the actuation of a flexible
membrane, allows the characterization of the viscoelastic
properties of cells in small volumes of suspension by loading
them in compression and observing the cell deformation in
time. From this experiment, we can determine the character-
istic time constant of recovery of cells.
As a first proof-of-concept, we characterized two different
cell types known to have a different cytoskeletal structure,
3T3 fibroblasts and HL60 neutrophilic promyelocytes.
Indeed, these showed a substantially and significantly
different response in the device and could be clearly distin-
guished on the basis of the calculated characteristic recovery
time constant. Also, the effect of breaking down the actin
network,themainmechanicalcomponentofthecytoskeleton,
by a treatment with Cytochalasin D, resulted in a dramatic
increase of the measured characteristic recovery time con-
stant. Experimental variations in loading force, loading time,
and surface treatment of the device also influenced the
measured characteristic recovery time constant significantly.
The device can be used to distinguish between cells with
different mechanical structure, and makes it possible to
study changes in the mechanical response due to cell
treatments, changes in the cell’s micro-environment, and
mechanical loading conditions. This allows, for example, a
systematic study of the effect of biological remodeling of
the cell. Also, (adherent) cells may be grown in the device
itself before testing. The method may be further developed
to aid in the selection of a certain type of cell, cells in
particular stages, or in isolating affected cells from healthy
cells for a variety of diseases. In conclusion, the main
characteristics and advantages of our device that distinguish
the method from existing approaches, are:
1. Whole-cell mechanical properties are probed
2. The device is simple and easy to use
3. Only small volumes of cell suspension are needed
4. The microenvironment of the cells can be controlled by
changing the working fluids and temperature, and by
surface treatments
5. The loading conditions can be varied in a flexible way
6. The device allows, in principle, to characterize multiple
cells simultaneously in the central area of the device
where uniform loading conditions exist, if the cells
have approximately the same size.
In the future, the device can be extended with a pressure
sensor and/or a measurement of the PDMS membrane
deflection, which would allow the quantitative determina-
tion of elastic moduli, though at the expense of an increased
complexity,
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